Ketamine Troches: Dosage, Effects, and How to Use

· Updated May 15, 2026Ketamine Therapy· Reviewed by Mai Shimada, MD
Ketamine Troches

TL;DR

A ketamine troche is a flavored sublingual lozenge — typically 100–200 mg — that dissolves under the tongue for at-home treatment of depression, anxiety, and PTSD.

  • Bioavailability: ~25–30%, lower than IV (100%) but sufficient for therapeutic effect with proper dosing
  • Onset: 10–20 minutes after dissolution begins
  • Peak: 30–60 minutes
  • Duration of session effects: 1.5–3 hours
  • Antidepressant benefit: can persist for days or weeks, similar to IV ketamine
  • Cost: significantly lower than IV infusions or Spravato — typically prescribed via compounding pharmacy
  • Access: requires a licensed physician prescription, usually within a structured ketamine-assisted therapy program

Troches are the format used in most at-home ketamine therapy programs because they combine the antidepressant effects of clinical ketamine with the convenience of taking medication at home.

What is a ketamine troche?

A troche (rhymes with "broke-y") is a slow-dissolving lozenge designed to release medication through the mucous membranes of the mouth — either under the tongue (sublingual) or between the cheek and gum (buccal). Ketamine troches are compounded specifically for psychiatric use and contain a measured dose of ketamine, typically 100–200 mg, along with a flavor base.

Why this route instead of swallowing a pill?

Swallowing ketamine triggers significant first-pass liver metabolism, which destroys most of the dose before it reaches the brain. Sublingual absorption bypasses the liver and delivers a larger fraction of the dose directly into the bloodstream — about 25–30% bioavailability, versus roughly 10–20% if swallowed.

The trade-off vs. IV: lower bioavailability but no needles, no clinic visit, and substantially lower cost.

How long does a ketamine troche last?

There are two timeframes patients care about — the session itself, and the antidepressant benefit afterward.

PhaseTiming
Dissolution time10–15 min (held under tongue, not chewed or swallowed)
Onset of effects10–20 min after dosing begins
Peak30–60 min
Perceptible session effects1.5–3 hours
Antidepressant benefitDays to weeks per session, often longer with maintenance dosing

Factors that shift the timeline:

  • Empty vs. full stomach — fasting for 2–3 hours before a session is standard
  • How long you hold it sublingually — more dose absorbed if held longer before swallowing residual saliva
  • Cumulative protocol — patients who have done multiple sessions often respond faster

How is the dose determined?

Ketamine troche dosing is highly individualized and set by the prescribing physician based on:

  • Body weight
  • Diagnosis and severity (TRD typically uses higher doses than anxiety)
  • Prior ketamine response
  • Concurrent medications

Typical starting doses are 100–150 mg, titrated based on response and tolerability. Some patients stabilize at lower doses; some require 200 mg or more. Self-adjusting the dose is unsafe — both higher (overdose, intense dissociation) and lower (sub-therapeutic) can lead to bad outcomes.

Ketamine troche vs. infusion vs. nasal spray

The three at-home and clinical formats compared:

FeatureTroche (sublingual)IV infusionNasal spray (Spravato)
Bioavailability~25–30%100%~50%
Onset10–20 minImmediate5–10 min
Duration of session1.5–3 hr40 min in-clinic40 min in-clinic + 2 hr monitoring
SettingAt home, telehealth supervisedIn-clinicCertified Spravato clinic
Dose precisionLess precise (mucosal absorption varies)Highly preciseStandardized 56/84 mg
Cost per sessionLowest$400–800$600–900
Insurance coverageRareRareCommon for TRD
Best forMaintenance + new patients with mild-moderate symptomsInitial response for severe casesPatients whose TRD diagnosis unlocks coverage

A common protocol: start with one or two in-clinic infusions to establish response, then transition to at-home troches for ongoing maintenance.

Sublingual ketamine troche: what the session feels like

Patients typically report:

  • Mild dissociation — a sense of floating, watching thoughts from a distance
  • Altered time perception — sessions can feel longer or shorter than they actually are
  • Enhanced introspection — emotional material that's hard to access in everyday life becomes more available
  • Visual or auditory changes — mild, usually with eyes closed
  • Reduced anxiety — both during and after the session

Most patients prefer a quiet, low-stimulation environment — eyes closed, headphones with calming music or a curated playlist, a supportive person available if needed. Many at-home programs provide structured guidance.

Post-session, the most common reports are improved mood, increased motivation, and a sense of relief from depressive "heaviness." These effects can build over a course of treatment.

Ketamine troche side effects

Common and short-lived:

  • Dizziness or lightheadedness
  • Nausea (less common when fasted and lying down)
  • Mouth tingling or numbness from the local anesthetic effect
  • Transient blood pressure elevation
  • Sleepiness in the hour after a session

Less common:

  • Blurred vision during the session
  • Brief confusion
  • Headache afterward

These typically resolve within hours. Patients should not drive or operate machinery for at least 4–6 hours after a session.

When to call your provider

  • Persistent confusion or dissociation lasting more than 6 hours
  • Severe headache, chest pain, or shortness of breath
  • Blood pressure spike that doesn't resolve

Is ketamine in troche form safe?

When prescribed by a licensed physician and used within a structured protocol, ketamine troches have a favorable safety profile. The risks come from misuse:

  • Self-prescribing — buying ketamine outside a medical context bypasses the screening that catches contraindications (uncontrolled hypertension, certain psychiatric conditions, pregnancy)
  • Combining with other substances — alcohol, benzodiazepines, and other sedatives compound dissociation and impair breathing
  • Escalating dose without supervision — tolerance builds; chasing the same intensity can lead to bladder issues and cognitive effects seen in chronic recreational users

A physician-led program handles all of these — initial assessment, dose titration, ongoing monitoring, and adjustment.

FAQs

How do you use a ketamine troche?

Place the troche under the tongue or between the cheek and gum. Let it dissolve over 10–15 minutes without chewing or swallowing prematurely. Your provider will give specific instructions on whether to spit or swallow the remaining saliva — this affects the dose absorbed. Remain seated or lying down in a comfortable, low-stimulation environment during and after dissolution.

Can you swallow a ketamine troche?

Swallowing the dissolved material isn't harmful but reduces effective dose substantially — first-pass liver metabolism breaks down most swallowed ketamine. The sublingual or buccal route is preferred. Follow your provider's specific instructions.

Can ketamine troches be used for chronic pain?

Yes — ketamine HCl troches are sometimes prescribed off-label for certain types of chronic pain, particularly neuropathic pain, because ketamine modulates pain signal transmission via NMDA receptor blockade. The protocol is different from psychiatric use; talk to a pain specialist.

How is troche dosing decided?

By the prescribing physician, based on weight, diagnosis, prior ketamine response, and concurrent medications. Typical starting doses are 100–150 mg, titrated over the first few sessions. Self-adjusting is unsafe.

How often are troches taken?

Protocols vary widely. Common patterns: an initial induction series (e.g., 2 sessions per week for 3 weeks) followed by maintenance (every 1–4 weeks). Some patients respond well to a more sparse schedule once stable. Your provider sets the cadence based on response.

Are ketamine troches covered by insurance?

Rarely, because they are compounded and used off-label. Most patients pay out of pocket, though many providers accept HSA/FSA. See pricing for current cost.


Related Articles


Considering ketamine therapy? Isha Health offers physician-led at-home treatment with an 88.8% improvement rate. Check appointment availability.

88.8% of Isha Health patients with moderate-to-severe depression show measurable improvement

Based on 546 patients and 1,900+ validated assessments. See our clinical outcomes →

Related Posts

Psychedelic Integration Therapy

Psychedelic Integration Therapy: A Complete Guide

Explore Psychedelic Integration Therapy, its benefits, process, and how it helps integrate psychedel...

Does Ketamine Therapy Get You High

Does Ketamine Therapy Get You High

Wondering if ketamine therapy gets you high? Learn how medical doses affect the mind, what sensation...

nasal ketamine and ketamine infusion

Nasal Ketamine and Ketamine Infusion

Discover the difference between nasal ketamine and ketamine infusion treatments for depression and p...

Stay informed on ketamine therapy

Research updates, clinical insights, and mental health resources — delivered to your inbox.